chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 79 year old male with ice cream and butter allergy and a history of chickenpox, who on 27-MAR-2007 was vaccinated with ZOSTAVAX (Oka/Merck) (lot# 656394/0162U) into the right deltoid (upper arm subcutaneous). Concomitant therapy included DURABAC, aspirin, ferrousSO4, SYNTHROID, lisinopril-HCTZ, ZOCOR, tamsulosin hydrochloride, folic acid, amiodarone hydrochloride, travoprost, COUMADIN, clobetasol propionate, VALTREX and ALLEGRA. On 05-SEP-2008 the patient developed four lesions distributed in the lower right side towards his abdomen, the patient had some bloody discharge and he complained of he was having fever 101.5 and was diagnosed as shingles. He had large oozing blisters and pain, which he quanitified as a 9 out of 10. He was given samples of LEVAQUIN 750 mg and LYRICA 75 mg PO HS x 1 week, then to increase to BID if still symptomatic. Shingles was persisting. No PCR sample was taken. No further information is available.
Pt up fr nap felt hot, stiffened & had convuls sx; t103.8 R;
THE MOTHER OF THE PATIENT INDICATES THAT AFTER THE FIRST DOSE BEING ADMINISTERED THE PATIENT DEVELOPED AN ADVERSE REACTION AND HAD A RASH APPEARING FISRT AT THE SITE WHERE THE VACCINE WAS ADMINISTERED (LEFT ARM),  THEN IT APPEREAD ON HER WHOLE BODY .
On the evening of the 11th of July I started to get a headache and it was difficult to keep my glasses on and a scratchy throat. On Tuesday the 12th I went on about my regular day and came back and after lunch fell asleep and woke up with the same headache as Monday but worse. I took some TYLENOL and it only dulled the pain some. No other symptoms. I woke up between 2/3 am on the 13th and I wasn't breathing well. I used the pulse oximeter and my oxygen saturation was 92. My nostril were clogged so I used FLONASE. I took a COVID-19 at home test and it was positive. I called my Dr. and they sent me PAXLOVID and started it on the evening of the 12th. I had a fever that went to 102. On the 14th I had a tele visit. By Friday I was feeling 70% better and still with a low 99.3 fever. By Mon 18th I did not have any symptoms and completed the PAXLOVID. I still had a bit of fatigue. Now I don't even have fatigue.
Patient received first dose of covid vaccine on 1/28/21. Reported dizziness, fainting, and mild shortness of breath.
Elevated heart rate (130 at rest for 10+ hours, my normal is 70-80) Elevated blood pressure (150/89 at rest for 10 + hours, my normal is 110/70) Extreme headache, light sensitive Nausea  Mild anaphylaxis itching/burning/tingling in lips, tongue and throat Feeling of intoxication, disoriented, slurred speech, dizziness  Rash/redness that spread beyond injection site on to back of shoulder Agitation  Itchiness Peeling of skin in mouth/cheeks Blisters on roof of mouth  Chest tightness with normal breathing Jaw pain Treatment as listed below; continue with Benadryl every 6 hours and ibuprofen; return if symptoms continue or worsen
Rash, red and itching, at injection site. Extended plus or minus 2+ inches width and 4+ inches length over 5 days.. Continued from 01/30/2021, red and itching, gradually receding. Subsided as of 02/07/2021
7 days after (01/09/21) getting injection, the injection site became itchy, swollen, and warm to the touch. Before it had a small dime sized red spot at injection site with no reaction or issue. then on the 7th (01/09) day the side was about the size of a 50 cent piece, then on the 8th (01/10) day it had doubled in size and was extremely warm, itchy, and swollen. I did an appointment via virtual health and the doctor diagnosed it as Cellulitis. I was put on a week worth of cephalexin 500mg 4x a day. after 3 doses the swelling and itching went down drastically.
Information was reported in a letter to the editor concerning a 24 year old resident of developmental center with panhyopituitarism, who had been previously vaccinated against all childhood diseases and had serosusceptibility to varicella who was vaccinated SC with a 0.5ml dose of varicella virus vaccine live. Concomitant therapy included 22.5mg/d of hydrocortisone. After 18 days the pt had a fever of 38 to 39 degrees C and a maculopapular rash on her trunk. On day 19, the papules changed to monolocular collapsing vesicles. On day 20, a similar rash appeared on her extremities and face. Successive crops of rash resulted in the presence of several stages of vesicle maturation. The total number of lesions was estimated to be 150 to 200 and it was reported that she had chickenpox. On day 21, she developed more skin lesions and her temp rose to 39degrees C with mild dehydration. A chest radiograph revealed a right basilar pulmonary infiltrate. It was reported that the pt had pneumonia. From day 21 to day 29 the pt was hospitalized in an isolation room with negative pressure to prevent airborne viral transmission and received 1260 mg/d of acyclovir intravenously. It was reported that the pt eventually recovered. The reporter felt that the most likely cause of this illness was the vaccination because of its temporal consistency with the incubation period of varicella (14 to 21 days) and the lack of any contemporary cases of wild type varicella among staff or other residents. Additional information has been requested.
approx 5min p/vax pt stated need to sit down then fell against wall slid to floor & began to shake became stiff & eyes fixed;mom got pt alert;pt was unaware of surrounds for a short time;stated was parasympathetic rxn not allerg rxn
Initial literature case retrieved via a search of the scientific literature on 15 April 2015. A 19-year-old male, with no history of previous skin disorders, received ACAM2000 on an unspecified date. Two weeks post-vaccination, he presented with pruritic, slightly painful targetoid vesicular lesions involving bilateral hands, left knee, left buttock, genitalia, left elbow, and lower lip. The inoculation site was within normal limits, with no satellite lesions or evidence of secondary bacterial infection. Past medical history was negative for exposure to livestock, exotic animals, known insect bites, herpes virus infections, oral medications, or bacterial respiratory infections. The patient was diagnosed with erythema multiforme, and after consultation with infectious disease specialists was treated with histaminic blockade. He experienced complete resolution of lesions without scarring 18 days after initial presentation. Documents held by sender: None.
Fever >103, injection site pain, fatigue, headache, chills, injection site erythema 3x3 inches, raised, nausea. Fever peaked 32hrs after injection site swollen to golf ball size hard for 3 days, now about quarter sized, raised, hard for 6 day after, itches. Still have quarter sized hard lump with pain and itching.
Diffuse erythematous macules/papular rash with congestive and low grade fever.  10 days after immunizations.
Patient was accidentally given the Pfizer vaccine rather than the Moderna vaccine for her booster. Staff called to check on the patient on 10/20/21 and the patient's daughter reported that she had a light headache but was otherwise doing well.
Called pharmacy on to get information about the vaccine given. RPh there unsure if lot number is KB996 or KB99G. Pt given SHINGRIX then reported bruising that progressed across his body with eventual hematuria. Pt referred by outpatient MD for hematology due to anemia follow up and it was discovered his Factor VIII levels were undetectable and he had developed Bethesda + antibodies targeting his Factor VIII. Pt treated with NOVOSEVEN until HGB recovered. Pt is undergoing active treatment at this time with prednisone and cyclophosphamide + NOVOSEVEN. We are currently on day 5 of hospitalization but it is expected to be ongoing.
tired on Friday after shot,  extremely tired and feeling almost depressed all day Saturday, not as tired Sunday but still almost depressed. Friday and Saturday  cold, but no fever Cold sores erupted
Administered dosage labeled on the vial. This was a booster shot that was supposed to be 0.25ml. No adverse reaction or treatment required.
No adverse effects were noted. Moderna vaccine was given and client was only 16 year old. Once it was noted the family was called, the patient was called and the second dose was held. The clinic was on a college campus and unfortunately only students/faculty 18 years and older were instructed to sign up. He was signed up and vaccine was administered.
patient received expired dose; This case was reported by a other health professional via other manufacturer and described the occurrence of expired vaccine used in a patient who received HAB (Twinrix) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, Hepatitis B vaccine for prophylaxis and benzathine benzylpenicillin (Bicillin La) unknown for product used for unknown indication.   On an unknown date, the patient received Twinrix, Twinrix Pre-Filled Syringe Device, Hepatitis B vaccine and Bicillin La at an unknown dose and frequency. On an unknown date, unknown after receiving Twinrix, Twinrix Pre-Filled Syringe Device and Hepatitis B vaccine, the patient experienced expired vaccine used. The action taken with Bicillin La was unknown. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 27-MAY-2022 Reporter's Comments: The pharmacy intern called from a health system regarding Bicillin LA. The reporter's supervisor informed her that, they had a patient that received an expired product and were trying to get more information. The pharmacist was working with the patient. The reporter believed that, they gave expired dose of Twinrix to the patient. The patient might have received expired dose of Hepatitis B vaccine as well. She did not have a lot number or expiration date of product. On an unknown date, unknown after receiving Bicillin LA, the patient experienced expired product used. No further details were provided. The reporter consented to follow up. Additional Supportive Information: The patient received an expired dose of Twinrix, Hepatitis B vaccine,which led to expired vaccine used.
Adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Adverse reaction). At the time of the report, VACCINATION COMPLICATION (Adverse reaction) outcome was unknown. Not Provided          The patient took the second dose of the mRNA-1273, hence action taken with the vaccine in response to the events was not applicable.   No concomitant medication was reported.  No treatment medication was reported.
Red rash developed after 4 days, rash is itchy, pimple formed above rash.
Headache, chest pain, leg weakness, dizziness, shortness of breath, chills,
Swelling in lymph nodes under my right arm with a good amount of discomfort for two days following shot, on third day after, the swelling, which felt like fluid, had drifted into my right breast, with a great deal of swelling/fluid.  I'm having a lot of discomfort with an achy pain in my underarm.  It feels like the shot was given to me in my underarm more than my arm.
Rash on face, neck, arms and hands.; This is a spontaneous report from a contactable other hcp (patient). A 24-year-old non-pregnant female patient first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number=EJ1685), via an unspecified route of administration on 21Dec2020 19:00 at Left arm at single dose for covid-19 immunization.  The COVID-19 vaccine was administered at Hospital. Medical history included eczema. No known allergies. Concomitant medication included levonorgestrel (NORTREL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced Rash on face, neck, arms and hands on 21Dec2020 22:00. No treatment received. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19.  The outcome of the event was not recovered.
Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022; Dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Hyperlipidemia, Hypertension and Allergy. Concomitant products included LEVOCETIRIZINE DIHYDROCHLORIDE for Allergy.    On 06-Apr-2022 at 4:04 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 4:04 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient did not had any allergies to food or medications. Patient did not had COVID-19 positive or negative preceding month of vaccination.  Total number of doses/vials was 36.  Vial did not undergo any temperature excursions. Patient not experienced any side effects yet.   No treatment information was provided.
Pt recvd vax 27AGU92 had fatigue for 48 hrs; resolved; 28SEP92 had fatigue that is ongoing;
Extreme head pain, nerve ending pain-all over-preceded by nearly losing consciousness on the street while walking my dog-several hours after the vaccine was given.
Big red area around the injection site.  The redness is greater below the injection site then above it.  Patient is feverish (100) and area is hot to the touch.
Information has been received from a physician who heard that two patients had ALS (amyotrophic lateral sclerosis) after vaccinated with a dose of GARDASIL (lot # not reported, dose number unknown) on an unspecified date. One of the "hearsay" was already captured in WAES# 0803USA02516 (same age, same location and same outcome). At the time of reporting, it was not reported if the patient had sought medical attention and the outcome was unknown. Upon internal review, ALS (amyotrophic lateral sclerosis) was considered to be an other important medical event. This is one of several reports received from the same source. Attempts are being made to verify the existence of identifiable patient in this report. Additional information will be provided if available.
It started with flu-like symptoms -- chills, fever, muscle aches, and headache all of which lasted throughout the next day following the vaccine.  Also on that day, I had a flare up of Raynaud's that lasted for the next 3 to 4 hours.  The flu-like symptoms lasted about 48 hours, after which I felt an overwhelming fatigue that has continued.
Blood clot disorder; This is a spontaneous report from Pfizer sponsored program. A contactable female consumer (patient) reported for herself that she received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 on an unspecified date and dose 2 on 19May2021, both via an unspecified route of administration (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Caller went on her 2nd dose today 19May2021, she was asked a question if she had a blood clot disorder, she was not asked about this on the 1st dose, and apparently, she was having a blood clot disorder on an unspecified date. She asked the people in the facility if she needed to be concerned, and they said that she didn't need to worry about it, however she wanted to make sure that everything was fine or should she watch out for something. Outcome of event was unknown.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Eyes won't stop twitching spastically all day from the moment of waking until sleeping. Eyes twitch at least 1000 times a day. Right eye twitches more than left.; Cognitive disconnect after first and second doses for a week; Brain fog; emotional disassociation.; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age (adult) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number was EW 0177) dose 1 via an unspecified route of administration, administered in arm right on an unspecified date (at the age of 21-year-old) as dose 1, single and dose 2 via an unspecified route of administration, administered in arm right on an unspecified date (Batch/Lot Number: EW 0172; at the age of 21-year-old) as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications (other medications within 2 weeks of vaccination) included docosahexaenoic acid, eicosapentaenoic acid, tocopherol (OMEGA 3); ascorbic acid (VITAMIN C); vitamin D3; curcuma longa (TURMERIC); all concomitant medications taken for an unspecified indication, start and stop date were not reported. Patient received the most recent dose of vaccination at pharmacy or drug store facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unspecified date, the patient's eyes would not stop twitching spastically all day from the moment of waking until sleeping. Eyes twitch at least 1000 times a day. Right eye twitched more than left. Cognitive disconnect after first and second doses for a week. Brain fog and emotional disassociation. The events immediately followed both vaccines but the eye twitching started more profusely after the second dose. No hospitalization prolongation was reported. No treatment received for events. The outcome of the events was not resolved.  No follow-up attempts are possible. No further information is expected.
Pt recvd measles vax on 23APR91 & on 5MAY91 pt devel fever of 103.5, a morbilliform, pigmented rash, nausea, diarrhea, photophobia, asthenia; tx APAP;
Within 5 hours, serious vomiting and a sore arm.  The following day a pressure in my head and sparadic painful head pains.  Facial twitching (in various areas).  The headache and pressure continued for 10 days and I am still experiencing facial and leg twitches to date.  The most worrying effect was around 6 weeks after having the vaccine.  I felt ill and my left arm was in a lot of pain.  It felt Like I had arthritus throughout my body.  I took a bath and later experienced pain stretching from my arm to my chest.  I also experienced more hair loss than normal.
Adverse Events: No issues immediately after the injection. Maybe some minor joint ache around hands No issues ~ 2 weeks after the injection  Around 20 days after the injection: - High blood pressure (~125/80) whereas, my average BP is 100/60 (measured ~30 minutes after waking) - High blood pressure is sustained since  then (maybe it goes as low as 110/70 but usually, it's extremely high after waking up - Joint ache in hand and arms - Body chills followed by warmth in chest and arms (around the elbow) - Temperature is normal (97-98 deg F) - Diarrhea but no intestinal pain - blood oxygenation is ok (97 - 99) - Appetite is ok - No cough or congestion  Around 23 days after the injection: - All reported symptoms still apply - Back pain around lower rib-cage
Sinus congestion; tachycardia; This is a spontaneous report from a contactable other healthcare professional (hcp reporting for self). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on 29Jan2021 11:30 at a single dose in the left arm for COVID-19 immunization. Medical history included anxiety and seasonal allergies, both from an unknown date and unknown if ongoing. The patient had no Covid prior vaccination. Concomitant medications included mometasone furoate (FLONASE), escitalopram and unspecified daily multivitamin. Patient had no other vaccine in four weeks. The COVID-19 vaccine was administered in the hospital. On 30Jan2021 17:00, patient experienced sinus congestion and tachycardia. No treatments received in response to the events reported. Patient was not tested for covid post vaccination. The patient recovered in Jan2021 from the events sinus congestion and tachycardia.   Information on the lot/batch number has been requested.
Patient experienced extreme pain approx 5 hours post vaccination. Her arm went (L) numb and she had no muscle control. Feeling began to return the next day by 50%. By 10/28/13 she was normal.
Right leg swollen small amt, feverish, diarrhea. Dx: localized rxn to Dtap inj
The evening that I received my Booster shot, I started having these symptoms: chills, heat waves, cold sweats, headaches, muscle soreness, joint and bone aches.
This is a spontaneous report from a contactable consumer (patient). A female patient, of an unspecified age, received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# not reported), via an unspecified route of administration, on an unspecified date, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient experienced allergic reaction on an unspecified date, after receiving the first dose of the COVID-19 vaccine. The outcome of allergic reaction: unknown. No follow-up attempts possible. Information about lot/batch number cannot be obtained. No further information expected.
About 7 hours after injection, I got full body chills. I also felt slightly woozy and a little loopy, but that only lasted about 4-5 hours. (In addition, my body felt a little stiff and my hamstrings got really sore, but I think it was directly related to a squat workout I did the previous day.) My temperature was 99F.  I woke up every 2 hours from my sleep. The chills lasted about 10 hours after their onset.  I took Tylenol at the 10 hour mark, and then the chills stopped. Hamstring soreness also subsided.
Area of erythema, induration and swelling, (R) upper arm, around site of DTaP injection. Noted 8 cm x 9 cm on 8/3/11, pt seen on 8/4/11, redness & swelling slightly improved.
Pt with hot/warm arm following immunization.  Put on Keflex by MD.
<15mins post vaccination pt c/o numbness around her lips Vitals: BP 147/93, HR 94, RR 19. Pt stable and released from vaccination site.
Information has been received from a pharmacist who reported that a female patient had an allergic reaction from Pneumovax 23 vaccine as a child or young adult. The reporter did not know how much. No further information was provided. No further information is available.